Blackbaud Shares Surge After Upgrade to Buy Rating

Blackbaud, Inc. (NASDAQ: BLKB) saw its shares rise above the 200-day moving average during trading on Tuesday, following an upgrade from Wall Street Zen. The stock, which crossed a significant threshold, has a current 200-day moving average of $63.59 and peaked at $64.46 during the session. As of the latest trading, Blackbaud shares were valued at $63.52, with a trading volume of 180,374 shares.

The upgrade from Wall Street Zen marked a notable shift in sentiment, transitioning the stock from a hold rating to a buy rating. This follows a series of assessments from other research firms. On October 29, 2023, Stifel Nicolaus set a price target of $70.00 for Blackbaud. Meanwhile, Zacks Research increased its rating from hold to strong buy in a report dated November 3, 2023. Conversely, Weiss Ratings reissued a sell rating on October 8, 2023. Currently, three analysts have rated the stock as hold, while one has issued a sell rating, according to data from MarketBeat, which indicates a consensus rating of “Reduce” and an average target price of $73.00.

Institutional Investment Activity

Recent activity among institutional investors has indicated significant interest in Blackbaud. Notably, Raymond James Financial Inc. boosted its stake by 36.4% in the first quarter, owning 120,748 shares valued at approximately $7.49 million after acquiring an additional 32,194 shares. Similarly, Comerica Bank increased its holdings by 40.4%, now owning 20,485 shares worth around $1.27 million after purchasing 5,893 shares.

Cubist Systematic Strategies LLC exhibited a remarkable increase in its stake by 342.2%, acquiring an additional 66,851 shares, bringing its total to 86,388 shares valued at $5.36 million. EP Wealth Advisors LLC also increased its position by 11.8% and now owns 4,297 shares worth approximately $267,000. Overall, 94.21% of Blackbaud’s stock is owned by hedge funds and other institutional investors.

Financial Overview and Future Expectations

Blackbaud’s financial health is reflected in its market capitalization of $3.03 billion, a price-to-earnings ratio of -12.18, and a price-to-earnings-growth ratio of 2.77. The firm also has a beta of 1.09, indicating moderate volatility. Financial metrics such as the debt-to-equity ratio stand at 9.63, with both the quick and current ratios reported at 0.69.

The company announced its quarterly earnings on March 4, 2024, reporting earnings per share of $0.68 and revenue of $274.76 million. Analysts anticipate that Blackbaud will post an earnings per share of $3.05 for the current fiscal year.

Founded in 1981 and headquartered in Charleston, South Carolina, Blackbaud has established itself as a leader in providing cloud software and data intelligence solutions tailored for the social good sector. Its flagship products, including Raiser’s Edge NXT and Blackbaud Financial Edge NXT, enable nonprofit organizations, educational institutions, and healthcare providers to enhance donor engagement, streamline financial operations, and measure program effectiveness.

As Blackbaud continues to navigate the evolving market landscape, the recent upgrade and positive institutional interest may pave the way for sustained growth and investor confidence in the coming months.